IC15 Upper respiratory tract infections Flashcards

1
Q

risks factors of URTI

A

Close contact with children → daycares & schools increases risk
* Lack of personal/ hand hygiene

Medical disorder: people with chronic respiratory diseases
* ie: asthma/ allergic rhinitis ⇒ poorer innate immunity

Smoking

Immunocompromised individuals
* Cystic fibrosis, HIV, use of corticosteroids, transplantation, post-splenectomy

Anatomical abnormalities
* Facial dysmorphic changes, nasal polyposis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

common cold: clinical presentation

A

Low grade temperature; lack of high temperature (~37-38℃)
Rhinorrhea, nasal blockage, sneezing
Sore throat, productive cough
Headache, bodyache
normal heart rate, and lungs that are clear to auscultation
(No compromise in air entry for breathing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

common cold: microbiology

A

caused by rhinovirus/ coronavirus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

common cold: therapy
(also - general symptomatic relief for other conditions)

pharm & non-pharm

A

no indication for AB

provide only symptomatic relief
pharm
Paracetamol, NSAIDs, Nasal decongestants, Antihistamine, Lozenges, Mucolytics, Cough suppressants, Expectorant

non-pharm
Normal saline nasal irrigation, Warm water/tea, Honey

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

influenza: monitor therapy

symptoms improvement, nasal discharge

A
  • Mostly self-limiting & will recover in 7-10 days
    To see doctor if symptoms do not improve after 10 days/ worsening of symptoms (may be secondary infection)
  • Usually will feel better within 3-4 days but symptoms may linger for weeks
  • Normal for nasal discharge to change colour (clear → yellow)
    Important to not determine if infection is bacteria/ virus based on sputum colour
  • Cough may last 2-3 weeks
    May have post-nasal drip ⇒ irritates throat
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

influenza: possible complications

A
  • Primary viral pneumonia
    Due to weakened immune system ⇒ allows invasion of bacterial pathogen
  • secondary pneumonia → S.aureus, Streptococcus pneumoniae, haemophilus influenzae
  • Exacerbation of respiratory diseases
  • Myocarditis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

influenza: impact of infections

A

Influenza A & B ⇒ causes seasonal epidemics of diseases
* Occur all year round in SG, with small peaks in middle & end/ beginning of the year
* Temperate countries → usually higher rates of infections during winter

Influenza A ⇒ can cause pandemics
Influenza C ⇒ causes febrile mild upper respiratory illness; do not occur in epidemics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

influenza: monitor response
when to see doctor

A
  • symptoms do not improve after 10 days OR
  • Symptoms improve then develop new fevers, worsening dyspnea or cough
    Possible secondary bacterial infections; may require AB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

influenza: treatment
indications

patients at risk, normal patients

A
  • To initiate ASAP (best within first 48 hours, up to 5 days) from symptom onset for individuals fulfilling any of the criteria:
    Hospitalised
    High risk for complications
    Severe, complicated or progressive illness
  • Can be considered for others presenting within 48 hours of symptoms onset
    Beyond 48 hours ⇒ take symptomatic relief
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

influenza: treatment (drug choice)

MOA, dosing, SE

A

Oseltamivir

MOA: Neuraminidase inhibitor
Interferes with protein cleavage ⇒ inhibits release of new virus

Dose
PO 75 mg BD x5 days
Requires dose adjustment in renal impairment patients (CrCl <60 mL/min)

Possible AE: headache, mild GI discomfort [N/V]
* Generally well tolerated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

influenza: requirements for diagnostic testing + purpose

A

usually for hospitalised patients/ LTC to confirm indication for antivirals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

influenza: RF for complications

CAPON

A
  • Children < 5 years & elderly ≥ 65 years [age]
  • Women who are pregnant or within 2 weeks postpartum
  • Residents of nursing homes or long-term care facilities
  • Obese individuals with BMI ≥ 40 kg/m2
  • Individuals with chronic medical conditions
    ie: asthma, COPD, HF, DM, CKD, immunocompromised
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pharyngitis: general clinical presentation

A

Sore throat (worse with swallowing)
Fever
Erythema & inflammation of pharynx & tonsils
* With or without patchy exudates

Tender & swollen lymph nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

pharyngitis: viral clinical presentation

A

Erythematous tonsils without hypertrophy/ exudates

Low-grade fever, malaise, fatigue
Rhinorrhea, cough, hoarseness
Oropharyngeal lesions (ulcers/ vesicles)
Conjunctivitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

pharyngitis: bacterial clinical presentation

A

Tonsillar exudates & hypertrophy
Sore throat with tonsillar exudates
Fever
Cervical lymphadenopathy without typical viral symptoms
Swollen lymph nodes → to identify by pulsating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

pharyngitis: viral treatment

A

Usually self-limiting, do not require any antiviral treatment → give symptomatic treatment

17
Q

pharyngitis: causative agent for bacteria

A

S.pyogenes (beta-hemolytic strepA)

18
Q

pharyngitis: bacteria
possible complications

when does it occr

A

1-5 weeks after infection

Acute rheumatic fever ⇒ prevented with early initiation of effective AB
Occurs 2-4 weeks following infection of StrepA
Might cause presentations of arthritis, endocarditis, SC nodules

Acute glomerulonephritis ⇒ not prevented by AB

19
Q

bacterial pharyngitis: modified cantor criteria

A
  1. fever (1)
  2. swollen lymph nodes (1)
  3. tonsillar exudates (1)
  4. abscence of cough (1)
  5. age
    * 3-14 (1)
    * 15-44 (0)
    * >45 (-1)
20
Q

pharyngitis: viral causative agents

A

Rhinovirus, coronavirus, influenza, parainfluenza, Epstein-barr

21
Q

bacterial pharyngitis: treatment

duration of treatment

A

10 days

22
Q

bacterial pharyngitis: modified cantor criteria scores

additional testing, likelihood bacterial infection

A

Total: 0-1 points
No additional testing indicated
Low risk of S. pyogenes pharyngitis
Presumed viral
No antibiotics

Total: 2-3 points
Test for S. pyogenes pharyngitis
If test not avail, check for severity of condition
treat with antibiotic if positive

Total: 4-5 points
High risk for S. pyogenes pharyngitis
Initiate empiric antibiotics

23
Q

bacterial pharyngitis: treatment

first line

A

PO penicillin 250 mg q6h or amoxicillin 500 mg q12h

24
Q

bacterial pharyngitis: treatment

penicillin allergy

A

Non-severe: PO cephalexin 500 mg q12h
Common R1 side chain as penicillin & amoxicillin

others
PO azithromycin 500 mg OD
PO clarithromycin 250 mg q12h
PO clindamycin 300 mg q8h

Note: increasing resistance to macrolides
Generally can still challenge unless patient does not get better

25
Q

pharyngitis: monitoring outcomes

viral & bacterial symptoms relief

A

Viral pharyngitis: Sore throat should be <1 week only

Bacterial pharyngitis: fever & symptoms usually resolve within 1-3 days of starting treatment + resolution usually within 3-4 days
To see doctor if symptoms do not improve/ worsen

26
Q

Acute rhinosinusitis: pathogenesis

A
  • Direct contact with droplets of infected saliva/ nasal secretions
  • Bacterial cases usually comes after viral URTIs (common cold, pharyngitis)
  • Inflammation results in sinus obstruction (rhinorrhea)
    Nasal mucosal secretions trapped
    Medium of bacterial trapping & multiplication
27
Q

Acute rhinosinusitis: possible complications

& symptoms

A

Spreading of infection to orbits/ CNS ⇒ to refer to ED for further evaluation (imaging)

Symptoms: limited ocular movements, acute vision changes, confusion, unilateral weakness

28
Q

Acute rhinosinusitis: causative bacterias

A

Common: Streptococcus pneumoniae, Haemophilus influenzae
Others: Streptococcus pyogenes, Moraxella catarrhalis, anaerobic bacteria (G+)

29
Q

Acute rhinosinusitis: clinical presentation

A
  • Purulent nasal discharge, nasal congestion & obstruction, cough
  • Facial pain/ pressure, ear fullness/ pressure
  • Reduced sense of taste/ smell (hyposmia/ anosmia)
  • Headache, fever
  • Bad breath, dental pain
30
Q

Acute rhinosinusitis: diagnostic tests

A

not required unless no improvements even with treatment
to treat based on clinical presentation

31
Q

Acute rhinosinusitis: indication for therapy

A

Should have ≥ 1 of the following:

  • Symptoms persisting >10 days without clinical improvements
  • Severe symptoms:
    fever >39°C, purulent nasal discharge, facial pain lasting for >3 consecutive days
  • Worsening of symptoms after initial period of improvement, for >3 days (5-6 days)
    New onset fever, headache or increased nasal discharge
32
Q

Acute rhinosinusitis: therapy

duration of treatment

A

5-7 days

33
Q

Acute rhinosinusitis: therapy

first line + possible resistance

A

PO amoxicillin 500 mg q8h
If S.pneumoniae is resistant, it may also be resistant to amox/ clav → resistance is derived from PBP, not due to ꞵ-lactamase production

PO amoxicillin/ clavulanate 625 mg q8h
For Haemophilus influenzae ⇒ have resistance to amoxicillin due to ꞵ-lactamase production
Clavulanate → prevents binding of ꞵ-lactamase onto ꞵ-lactam ring

34
Q

Acute rhinosinusitis: therapy

penicillin allergy

A

Non-severe: PO cefuroxime 500 mg q12h
PO levofloxacin 500 mg OD or moxifloxacin 400 mg OD

35
Q

Acute rhinosinusitis: monitoring outcomes

viral vs bacterial

A

Viral/ non-severe bacterial sinusitis: counsel patient that symptoms typically lasts for 7-10 days & no AB is required
Severe bacterial sinusitis: Symptom improvement within 7-10 days
To see doctor if have development of persistent, severe or worsening symptoms
Signs & symptoms of complications → orbital/ CNS symptoms